Treatment of bEnd.3 cells with rTGF 1 led to a significant suppression of claudin-5 mRNA expression (Figure 4a)
Furthermore, the TIPS4PED platform will incorporate AI-driven modules, designed to optimise the creation and management of PEDs, while also integrating smaller-scale management tools like Building Management Systems (BMS) to enhance overall performance
Why Injections Instead of Oral Supplements
Novo Nordisk filed a New Drug Application for the CagriSema combination (cagrilintide 2.4 mg + semaglutide 2.4 mg) in December 2025, with an FDA decision anticipated in late 2026
BPC-157 is commonly described in research literature as a stable gastric pentadecapeptide and is studied in laboratory models involving gastric tissue, epithelial integrity, angiogenesis, tendon and ligament response, soft-tissue repair models, inflammation pathways and wound-healing research